Whether your organization is strategically outsourcing its pharmaceutical manufacturing operations, transitioning later-stage clinical trial materials from your CRO, or looking for a highly specialized capability, we’re here to help. Our experienced team integrates a comprehensive understanding of formulation development with our analytical validation expertise and works closely with our facility and process units to ensure a smooth transition while helping you avoid regulatory setbacks. DPT is serialization-ready.
Site and Technology Transfer Capabilities
- Formulation optimization based on in-house manufacturing equipment
- Pilot, clinical trial materials, and commercial-scale cGMP manufacturing
- Analytical method assessment, transfer or development, and analytical validation
- Commercial-scale process evaluation, development or adaptation, selection, and optimization
- Assessment of commercialized formulations, including rheology